Monte Rosa to Receive $37.5 Million Novartis Milestone Payment
Monte Rosa Therapeutics said it will receive a $37.50 million milestone payment from Novartis for the first patient visit.
Related stories
Shell CEO Says Shareholder Payouts Will Not Structurally Fall to 30% of CFFO
Shell’s CEO said the company will not allow shareholder payouts to structurally fall to 30% of cash flow from operations.
L impact | EQUITY | Oct 29, 2026, 03:17 PM UTC
Fiverr Shares Rise 6.3% After Q3 Results and Higher Guidance
Fiverr shares rose 6.3% in morning trading after the company reported third-quarter 2026 results and raised its full-year 2026 guidance ranges.
M impact | EQUITY | Oct 29, 2026, 03:17 PM UTC
Middle East Insurance Reports Q3 Profit of 181,389 Dinars
M impact | EQUITY | Oct 29, 2026, 03:17 PM UTC
Altria Reports Higher Q3 Profit and Raises FY26 Outlook
Altria reported earnings of $2.518 billion, or $1.51 per share, versus $2.375 billion, or $1.41 per share, a year earlier, and raised its fiscal 2026 outlook.
M impact | EQUITY | Oct 29, 2026, 03:16 PM UTC
Al-Nisr Al-Arabi Insurance Q3 Profit 903,027 Dinars
M impact | EQUITY | Oct 29, 2026, 03:16 PM UTC
Builders FirstSource shares jump 7.9% after quarterly results beat expectations
Builders FirstSource reported third-quarter 2026 results that beat Wall Street revenue and earnings expectations. Its shares rose 7.9% in morning trading.
M impact | EQUITY | Oct 29, 2026, 03:16 PM UTC